Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment ...

Viatris was formed in 2020 through the merger of Mylan and Pfizer’s Upjohn unit. The plant in Pithampur operates under the company name Mylan Laboratories Limited, according to the warning letter.